News

Foresight Diagnostics announces $58.75 Million Series B financing led by Foresite Capital to commercialize ultrasensitive liquid biopsy MRD testing platform

Apr 27, 2023 AURORA, Colo., April 27, 2023 /PRNewswire/ -- Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced today that it has closed an oversubscribed Series B financing round...

Molecular Designs releases their new Simplicity™ Gastrointestinal Pathogen Panel

Apr 11, 2023 BIRMINGHAM, Ala., April 11, 2023 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays, announces the release of its new Simplicity™ Gastrointestinal Pathogen Panel...

Foresight Diagnostics & leading cancer center to present solid tumor MRD data at AACR conference

Apr 04, 2023 AURORA, Colo., April 4, 2023 /PRNewswire/ -- Foresight Diagnostics, a leader in molecular cancer diagnostics, announced the presentation of a study in collaboration with a leading cancer center...

Factorial Biotechnologies collaborates with Watchmaker Genomics to dramatically simplify single-cell sequencing

Mar 28, 2023 SAN CARLOS, Calif., March 28, 2023 /PRNewswire/ -- Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, has announced a collaboration with Watchmaker...

Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences

Aug 31, 2022 Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® ("IPS"), a division of Interpace Biosciences and provider...

YDS Pharmatech helps uncover a novel viral recognition pathway: published in Nature Chemical Biology

Aug 18, 2022 YDS Pharmatech announced the publication of a paper revealing a novel human viral recognition mechanism in Nature Chemical Biology today. The publication was co-authored by Xing Che, Ph.D.,...

A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports

Jun 14, 2022 Flagship Biosciences, Inc., today announced the publication of a paper describing validation of a novel digital spatial biology assay in Scientific Reports. The assay, Tissue Insight (TI)...

DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus

Jun 09, 2022 DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE or lupus). The IFN-1 Test supports the advancement of...